Tirzepatide: A GIP/GLP-1 Dual Agonist for MASH. The New England Journal of Medicine , 2024, www.nejm.org/doi/full/10.1056/NEJMoa2401943
Ethan Lazarus, M.D., owner of Clinical Nutrition Center in Denver, Colorado, and former president of the Obesity Medicine Association
Uno de cada ocho adultos estadounidenses, unos 30 millones de personas, estn tomando estos medicamentos, segn una nueva encuesta de KFF
Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
GLP-1 and NMDA receptors are expressed throughout the mammalian brain and, although reports indicate that GLP-1 analogues engage central appetite circuits through distinct subpopulations of neurons (most notably in the brainstem and the hypothalamus) 36 , feedforward neural pathways modulated by inhibition of NMDA receptors specifically in GLP-1-receptor-positive neurons may differ from those engaged by exclusive activation of GLP-1 receptors
There are three primary reasons why you might feel colder than usual while on semaglutide